title: Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
authors.affiliation: Genética Molecular and Cardiología-Fundación Asturcor, Hospital Universitario Central Asturias, Oviedo, Spain. eliecer.coto@sespa.princast.es
authors.forename: Eliecer
authors.initials: E
authors.lastname: Coto
authors.forename: Mónica G
authors.initials: MG
authors.lastname: Castro
authors.forename: Ana I
authors.initials: AI
authors.lastname: Corao
authors.forename: Cristina
authors.initials: C
authors.lastname: Alonso-Montes
authors.forename: Julián R
authors.initials: JR
authors.lastname: Reguero
authors.forename: César
authors.initials: C
authors.lastname: Morís
authors.forename: Victoria
authors.initials: V
authors.lastname: Alvarez
mesh_terms: D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000235:genetics*; D064326:MEF2 Transcription Factors; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018006:Myogenic Regulatory Factors / Q000235:genetics*
chemical_list: D064326:MEF2 Transcription Factors; D018006:Myogenic Regulatory Factors